Abstract
We describe a specific and quantitative novel assay for biologically active human type I interferon (IFN), the MxR assay. It is based on a Vero cell line containing multiple copies of a hybrid gene consisting of the murine MX promoter, which is responsive to type I IFN, linked to the human growth hormone (hGH) transcription unit. Exposure of this cell line to IFN-α or -β for 12–48 hours results in the production of hGH that is measured by a commercially available radio-immune assay. The response to IFN-α is dose-dependent between 3 and 1000 units/ml. There is no response to TNF, IL-1 and a number of other cytokines and growth factors, and only a negligible response to IFN-γ.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Secher, D.S. 1981. Immunoradiometric assay of human leukocyte interferon using monoclonal antibody. Nature 290: 501–503.
Staehelin, T., Durrer, B., Schmidt, J., Takacs, B., Stocker, J., Miggiano, V., Stähli, C., Rubinstein, M., Levy, W.P., Hershberg, R. and Pestka, S. 1981. Production of hybridomas secreting monoclonal antibodies to the human leukocyte interferons. Proc. Natl. Acad. Sci. USA 78: 1848–1852.
Berthold, W., Merk, W. and Adolf, G.R. 1985. Immunoassay for the quantitation of human leukocyte interferon. Arzneim.-Forsch./Drug Res. 35: 364–369.
Kelder, B., Rashidbaigi, A. and Pestka, S. 1986. A sandwich radioimmunoassay for human IFN-γ. Methods in Enzymol. 119: 582–587.
Finter, N.B. 1981 Standardization of assay of interferons. Methods in Enzymol. 78: 14–22.
Allen, P.T. and Giron, D.J. 1970. Rapid sensitive assay for interferons based on the inhibition of MM virus nucleic acid synthesis. Appl. Microbiol. 20: 317–322.
Vassef, A., Beaud, G., Paucker, K. and Lengyel, P. 1973. Interferon assay based on the inhibition of double-stranded reovirus RNA accumulation in mouse L cells. J. Gen. Virol. 19: 81–87.
Sedmak, J.J. and Grossberg, S.E. 1973. Interferon bioassay: reduction in yield of myxovirus neuraminidases. J. Gen. Virol. 21: 1–7.
Jameson, P., Dixon, M.A. and Grossberg, S.E. 1977. A sensitive interferon assay for many species of cells: EM virus hemagglutinin yield reduction. Proc. Soc. Exp. Biol. Med. 155: 173–178.
Ishitsuka, H., Nomura, Y. and Takano, K. 1977. A simple and efficient microassay method for titration of interferon. Microbiol. Immunol. 21: 583–591.
Suzuki, J., Iizuka, M. and Kobayashi, S. 1981. Assay of interferon by reduction of viral RNA synthesis: A convenient assay for tracer experiments with monolayer cultures. Methods in Enzymol. 78: 403–409.
Hermodsson, S., Strannegård, O. and Jeansson, S. 1984. Bioimmunoassays (BIAs) of human interferon. Proc. Soc. Exptl. Biol. Med. 175: 44–51.
Schattner, A., Merlin, G., Wallach, D., Rosenberg, H., Bino, T., Hahn, T., Levin, A. and Revel, M. 1981. Monitoring of interferon therapy by assay of (2′–5′) oligo-isoadenylate synthetase in human peripheral white blood cells J. Interferon Res. 1: 587–594.
Giard, D.J. and Fleischaker, R.J. 1984. A study showing a high degree of interlaboratory variation in the assay of human interferon. J. Biol. Stand. 12: 265–269.
Reis, L.F.L., Le, J., Hirano, T., Kishimoto, T. and Vilček, J. 1988. Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-β2; and is inhibited by specific antibodies to IFN-β. J. Immun. 140: 1566–1570.
Jacobsen, H., Mestan, J., Mittnacht, S. and Dieffenbach, C.W. 1989. Beta interferon subtype 1 induction by tumor necrosis factor. Mol. Cell. Biol. 9: 3037–3042.
Fujita, T., Reis, L.F.L., Watanabe, N., Kimura, Y., Taniguchi, T. and Vilček, J. 1989. Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of second-messenger pathways. Proc. Natl. Acad. Sci. USA 86: 9936–9940.
Hug, H., Costas, M., Staeheli, P., Aebi, M. and Weissmann, C. 1988. Organization of the murine Mx gene and characterization of its interferon- and virus-inducible promoter. Mol. Cell. Biol. 8: 3065–3079.
Selden, R.F., Howie, K.B., Rowe, M.E., Goodman, H.M. and Moore, D.D. 1986. Human growth hormone as a receptor gene in regulation studies employing transient gene expression. Mol. Cell. Biol. 6: 3173–3179.
Staeheli, P., Haller, O., Boll, W., Lindenmann, J. and Weissmann, C. 1986. Mx protein: Constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44: 147–158.
Staeheli, P. and Haller, O. 1987. Interferon-induced MX protein: A mediator of cellular resistance to influenza virus, p. 1–23. In: Interferon 8 I. Gresser. (Ed.). Academic Press London.
Staeheli, P., Horisberger, M.A. and Haller, O. 1984. Mx-dependent resistance to influenza viruses is induced by mouse interferons α and β but not γ. Virology 132: 456–461.
Staeheli, P., Danielson, P., Haller, O. and Sutcliffe, J.G. 1986. Transcriptional activation of the mouse Mx gene by type I interferon. Mol. Cell. Biol. 6: 4770–4774.
Diaz, M.O., Ziemin, S., Le Beau, M.M., Pitha, P., Smith, S.D., Chilcote, R.R. and Rowley, J.D. 1988. Homozygous deletion of the α- and β1-interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. USA 85: 5259–5263.
Emeny, J.M. and Morgan, M.J. 1979. Regulation of the interferon system: Evidence that Vero cells have a genetic defect in interferon production. J. Gen. Virol. 43: 247–252.
Mosca, J.D. and Pitha, P.M. 1986. Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis. Mol. Cell. Biol. 6: 2279–2283.
Southern, P.J. and Berg, P. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Gen. 1: 327–341.
Dudli, Ch., Kaiser, V., Aguet, M., Joller, H., Pichler, W.I., Grob, P.J. and Fontana, A. 1986. Zirkulierendes Interferon bei Patienten mit systemischem Lupus erythematodes. Schweiz. Med. Wschr. 116: 104–109.
Goetschy, J.-F., Zeller, H., Content, J. and Horisberger, M.A. 1989. Regulation of the interferon-inducible IFI-78K gene, the human equivalent of the murine Mx gene, by interferons, double-stranded RNA, certain cytokines, and viruses. J. Virol. 63: 2616–2622.
Wathelet, M.G., Clauss, I.M., Nols, C.B., Content, J. and Huez, G.A. 1987. New inducers reveiled by the promoter sequence analysis of two interferon-activated human genes. Eur. J. Biochem. 169: 313–321.
Wathelet, M.G., Clauss, I.M., Content, J. and Huez, G.A. 1988. Regulation of two interferon-inducible human genes by interferon, poly(rl).poly(rC) and viruses. Eur. J. Biochem. 174: 323–329.
Barrett, A.D.T., Hunt, N. and Dimmock, N.J. 1984. A rapid method for the inactivation of virus infectivity prior to assay for interferons. J. Virol. Meth. 8: 349–351.
Streuli, M., Hall, A., Boll, W. Stewart II, W.E., Nagata, S. and Weissmann, C. 1981. Target cell specificity of two species of human interferon-α produced in Escherichia coli and of hybrid molecules derived from them. Proc. Natl. Acad. Sci. USA 78: 2848–2852.
O'Kelly, P., Thomsen, L., Tilles, J.G. and Cesario, T. 1985. Inactivation of interferon by serum and synovial fluids. Proc. Soc. Exptl. Biol. Med. 178: 407–411.
Luster, A.D. and Ravetch, J.V. 1987. Genomic characterization of a gamma-interferon-inducible gene (IP-10) and identification of an interferon-inducible hypersensitive site. Mol. Cell. Biol. 7: 3723–3731.
Fan, X., Stark, G.R. and Bloom, B.R. 1989. Molecular cloning of a gene selectively induced by gamma interferon from human macrophage cell line U937. Mol. Cell. Biol. 9: 1922–1928.
Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. 1989. Current Protocols in Molecular Biology. Greene Publ. Ass. and Wiley-Interscience, NY.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lleonart, R., Näf, D., Browning, H. et al. A Novel, Quantitative Bioassay for Type I Interferon Using a Recombinant Indicator Cell Line. Nat Biotechnol 8, 1263–1267 (1990). https://doi.org/10.1038/nbt1290-1263
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt1290-1263
This article is cited by
-
Effective SARS-CoV-2 replication of monolayers of intestinal epithelial cells differentiated from human induced pluripotent stem cells
Scientific Reports (2023)
-
Expression of Biologically Active Human Recombinant Interferon Alpha 2b in Human Breast Cancer Cell Line Bcap-37
Applied Biochemistry and Biotechnology (2013)
-
Species-independent bioassay for sensitive quantification of antiviral type I interferons
Virology Journal (2010)
-
Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5‐HT1B and 5‐HT1D receptors expressed in various mammalian cell lines
British Journal of Pharmacology (1998)